XML 63 R36.htm IDEA: XBRL DOCUMENT v3.25.4
BUSINESS ACQUISITIONS & DISPOSITIONS Business Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Abstract]      
Business Combination, Recognized Asset Acquired and Liability Assumed The purchase price allocations for these acquisitions were preliminary at December 31, 2025. The valuation of acquired assets and assumed liabilities included the following:
BioReference Health (2025)Community Health Systems Inc.Other Acquisitions Closed During the Year Ended December 31, 2025Measurement Period AdjustmentsAmounts Acquired During Year Ended December 31, 2025
Cash and cash equivalents$— $— $0.2 $— $0.2 
Accounts receivable— — 0.6 — 0.6 
Inventories— — 0.9 — 0.9 
Property, plant, and equipment— — 7.9 (0.8)7.1 
Goodwill105.8 91.4 90.6 10.4 298.2 
Intangible assets119.2 103.1 100.8 (23.3)299.8 
Total assets acquired225.0 194.5 201.0 (13.7)606.8 
Accrued expenses and other32.5 — 25.3 (20.6)37.2 
Lease liabilities— — 3.0 — 3.0 
Other liabilities— — 2.5 6.9 9.4 
Total liabilities acquired32.5 — 30.8 (13.7)49.6 
Net assets acquired192.5 194.5 170.2 — 557.2 
Escrow payments for pending acquisitions
25.0 
Cash paid for acquisitions$192.5 $194.5 $170.2 $— $582.2 
 The purchase price allocations for these acquisitions were preliminary at December 31, 2024. The valuation of acquired assets and assumed liabilities include the following:
Baystate Medical CenterProvidence Medical FoundationWestpac Labs, Inc.Invitae Corp.BioReference Health (2024)
Other Acquisitions Closed During the Year Ended December 31, 2024
Measurement Period AdjustmentsAmounts Acquired During the Year Ended December 31, 2024
Inventories$— $— $1.8 $12.1 $— $— $2.0 $15.9 
Prepaid expenses and other— — — — — — 8.4 8.4 
Property, plant, and equipment7.2 0.9 — 76.7 9.1 1.3 28.1 123.3 
Goodwill70.7 25.9 45.1 100.4 107.4 41.0 (90.6)299.9 
Intangible assets79.8 29.2 50.8 113.2 121.1 46.2 44.3 484.6 
Total assets acquired157.7 56.0 97.7 302.4 237.6 88.5 (7.8)932.1 
Accrued expenses and other— — — — — — (3.9)(3.9)
Unearned revenue— — — 3.3 — — (3.3)— 
Lease liabilities7.2 0.9 — 58.3 — 0.6 — 67.0 
Total liabilities acquired7.2 0.9 — 61.6 — 0.6 (7.2)63.1 
Net assets acquired150.5 55.1 97.7 240.8 237.6 87.9 (0.6)869.0 
Less 2023 escrow payment30.0 — — — — — — 30.0 
Cash paid for acquisitions$120.5 $55.1 $97.7 $240.8 $237.6 $87.9 $(0.6)$839.0 
 The purchase price allocations for these acquisitions were preliminary at December 31, 2023. The preliminary valuation of acquired assets and assumed liabilities, include the following:
Jefferson HealthEnzo BioChemProvidence Health and Services - OregonTufts MedicineLegacy
Other Acquisitions Closed During the Year Ended December 31, 2023
Measurement Period AdjustmentsAmounts Acquired During the Year Ended December 31, 2023
Accounts receivable$— $(2.8)$— $— $— $2.0 $0.2 $(0.6)
Inventories— — 1.3 — — — — 1.3 
Prepaid expenses and other— 0.4 — — 0.2 0.3 0.6 1.5 
Property, plant, and equipment— — 4.7 — 3.3 6.5 (1.5)13.0 
Goodwill50.8 54.1 50.7 73.8 49.0 18.5 (29.4)267.5 
Intangible assets57.2 61.1 57.2 83.2 55.2 26.9 19.5 360.3 
Other assets2.2 — — — — 17.9 — 20.1 
Total assets acquired110.2 112.8 113.9 157.0 107.7 72.1 (10.6)663.1 
Accounts payable— — — — — 1.2 — 1.2 
Accrued expenses and other— — 3.9 — — 1.2 (8.3)(3.2)
Deferred income taxes— — — — — — (2.3)(2.3)
Other liabilities— — — — — (4.1)— (4.1)
Total liabilities acquired— — 3.9 — — (1.7)(10.6)(8.4)
Net assets acquired$110.2 $112.8 $110.0 $157.0 $107.7 $73.8 $— $671.5 
Business Combination [Line Items]      
Business Combination, Pro Forma Information [Table Text Block]
Had the aggregate of the Company’s 2025 acquisitions, that were accounted for as business combinations, been completed at January 1, 2024, the Company’s pro forma results would have been as follows:
Year Ended December 31,
20252024
Revenues$14,100.6 $13,213.1 
Net earnings attributable to LHI$903.5 $782.5 
Had the aggregate of the Company’s 2024 acquisitions, that were accounted for as business combinations, been completed at January 1, 2023, the Company’s pro forma results would have been as follows:
Year Ended December 31,
20242023
Revenues$13,353.6 $12,716.4 
Net earnings attributable to LHI$761.8 $423.3 
Had the aggregate of the Company’s 2023 acquisitions, that were accounted for as business combinations, been completed at January 1, 2022, the Company’s pro forma results would have been as follows:
Year Ended December 31,
20232022
Revenues$12,350.1 $12,126.3 
Earnings from continuing operations$397.2 $1,030.3 
Acquired amortizable intangible assets and their respective weighted average amortization periods
Intangible assets recognized from business acquisitions that closed during the year ended December 31, 2025, including the related measurement period adjustments, and their respective weighted-average amortization periods are as follows:
Amount
Weighted-average Amortization Period
(in Years)
Customer relationships$262.3 15.0
Non-compete agreements53.6 4.9
   Total
$315.9